Our researchers are making discoveries that will have a positive impact for people with both Hodgkin and non-Hodgkin lymphoma.
Our researchers are making discoveries that will benefit patients with both chronic and acute forms of leukamia.
In our Patient Need research we identified that myeloma should be a real priority for us when it comes to funding.
Other blood cancers
Conditions like MPN, MDS and MGUS are a priority for our researchers because in some cases if we can treat them, we can prevent other blood cancers developing. We'll have more information on our work around MGUS and MDS soon.